Delcath Systems

US · DCTH #3706 by market cap

15.38 -0.03 -0.19%

Live - 5344 symbols - heartbeat 322s ago · 2026-10-07 19:54

After-hours 15.38 0.00%

Market cap: 533.67M
P/E (TTM): 1,538.00
P/B: 4.41
EPS: 0.07
Div yield: 0.00%
52W pos: 78%

Reader sentiment Are you bullish or bearish on DCTH?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing

Total institutional ownership fell 1.1 percentage points.

Institutional ownership

Held by institutions: 50.85% -1.05pp
Institutions: 146
As of: 2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund27.48%

Hedge Fund19.60%

Individual/Insider7.55%

Public Company3.12%

Private Company0.22%

Insurance Company0.19%

VC/PE Fund0.12%

Government Pension Fund0.12%

Other41.60%

Top holders as of 2026-06-30

Rosalind Advisors, Inc. 9.51% · 3.30M sh

BlackRock 7.80% · 2.71M sh

Daniel Kaufman 5.09% · 1.77M sh

Vanguard Capital Management, LLC 4.04% · 1.40M sh

Propel Bio Management, LLC 2.51% · 871.46K sh

Geode Capital Management, LLC 2.11% · 733.12K sh

State Street Global Advisors 1.96% · 679.28K sh

Algert Global LLC 1.67% · 580.71K sh

Millennium Management LLC 1.63% · 566.37K sh

Divisadero Street Capital Management, LP 1.44% · 499.80K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 48 buys · 2 sells

Name	Role	Stake
Gerard Michel	Chief Executive Officer	0.99%
Vojislav Vukovic	Chief Medical Officer	0.49%
David Hoffman	General Counsel, Corporate Secretary & Chief Compliance Officer	0.25%
Steven Salamon	Independent Director	0.24%
Sandra Pennell	Senior VP of Finance and Principal Financial & Accounting Officer	0.22%
Gilad Aharon	Independent Director	0.15%
Kevin Muir	Former Vice President of Commercial Operations	0.07%
John Sylvester	Independent Chairperson	0.04%
Martha Rook	Chief Operating Officer	0.02%
Elizabeth Czerepak	Independent Director	--

Insider transactions most recent Form 4 filings

Date	Name	Role	Type	Shares	Price
2026-05-12	Elizabeth Czerepak	Independent Director	Other Derivative Acquisition	+22,500	$11.61
2026-05-12	Steven Salamon	Independent Director	Other Derivative Acquisition	+22,500	$11.61
2026-05-12	John Sylvester	Independent Chairperson	Other Derivative Acquisition	+22,500	$11.61
2026-05-12	Gilad Aharon	Independent Director	Other Derivative Acquisition	+22,500	$11.61
2026-05-12	Bridget Martell	Director	Other Derivative Acquisition	+22,500	$11.61
2026-03-05	Sandra Pennell	Senior VP of Finance and Principal Financial & Accounting Officer	Open Market Acquisition	+5,533	$9.04
2026-03-01	Gerard Michel	Chief Executive Officer	Open Market Acquisition	+11,200	$8.96
2026-02-16	Gerard Michel	Chief Executive Officer	Other Derivative Acquisition	+97,500	--
2026-02-16	Gerard Michel	Chief Executive Officer	Other Derivative Acquisition	+195,000	$9.40
2026-02-16	Vojislav Vukovic	Chief Medical Officer	Other Derivative Acquisition	+28,250	--
2026-02-16	Vojislav Vukovic	Chief Medical Officer	Other Derivative Acquisition	+56,500	$9.40
2026-02-16	Sandra Pennell	Senior VP of Finance and Principal Financial & Accounting Officer	Other Derivative Acquisition	+28,250	--
2026-02-16	Sandra Pennell	Senior VP of Finance and Principal Financial & Accounting Officer	Other Derivative Acquisition	+56,500	$9.40
2026-02-16	Martha Rook	Chief Operating Officer	Other Derivative Acquisition	+28,250	--
2026-02-16	Martha Rook	Chief Operating Officer	Other Derivative Acquisition	+56,500	$9.40
2026-02-16	David Hoffman	General Counsel, Corporate Secretary & Chief Compliance Officer	Other Derivative Acquisition	+28,250	--
2026-02-16	David Hoffman	General Counsel, Corporate Secretary & Chief Compliance Officer	Other Derivative Acquisition	+56,500	$9.40
2026-02-16	Kevin Muir	Former Vice President of Commercial Operations	Other Derivative Acquisition	+28,250	--
2026-02-16	Kevin Muir	Former Vice President of Commercial Operations	Other Derivative Acquisition	+56,500	$9.40
2025-11-20	John Sylvester	Independent Chairperson	Open Market Acquisition	+4,386	$8.89

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.